<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="SciencesChina[â€¡], The Hong Kong Polytechnic UniversityHong Kong[Â§], Hangzhou Institute for" exact="Advanced" post="Study, UCASChina[âˆ¥], Jianghan UniversityChina[âŠ¥], University of Chinese Academy of"/>
 <result pre="of Chinese Academy of SciencesChina *Email: gbjiang@rcees.ac.cn. epub: 2020-03-03acs.est.0c01102received: 2020-02-21(C)" exact="American" post="Chemical Society, 2020This article is made available via the"/>
 <result pre="global pandemic. In the last two decades, the emergence of" exact="viral" post="epidemics poses great threats to human health and society."/>
 <result pre="epidemics poses great threats to human health and society. These" exact="infectious" post="viruses have been identified as hemorrhagic fever viruses (Lassa,"/>
 <result pre="as hemorrhagic fever viruses (Lassa, Ebola), novel coronaviruses including severe" exact="acute" post="respiratory syndrome CoV (SARS-CoV), Middle East respiratory syndrome MERS-CoV),"/>
 <result pre="hemorrhagic fever viruses (Lassa, Ebola), novel coronaviruses including severe acute" exact="respiratory" post="syndrome CoV (SARS-CoV), Middle East respiratory syndrome MERS-CoV), and"/>
 <result pre="fever viruses (Lassa, Ebola), novel coronaviruses including severe acute respiratory" exact="syndrome" post="CoV (SARS-CoV), Middle East respiratory syndrome MERS-CoV), and highly"/>
 <result pre="coronaviruses including severe acute respiratory syndrome CoV (SARS-CoV), Middle East" exact="respiratory" post="syndrome MERS-CoV), and highly pathogenic influenza. Coronaviruses (CoVs), as"/>
 <result pre="including severe acute respiratory syndrome CoV (SARS-CoV), Middle East respiratory" exact="syndrome" post="MERS-CoV), and highly pathogenic influenza. Coronaviruses (CoVs), as a"/>
 <result pre="Alphacoronavirus, Betacoronavirus (Î²CoV), Gammacoronavirus, and Deltacoronavirus. Two novel Î²CoVs, severe" exact="acute" post="respiratory syndrome CoV (SARS- CoV) and Middle East respiratory"/>
 <result pre="Betacoronavirus (Î²CoV), Gammacoronavirus, and Deltacoronavirus. Two novel Î²CoVs, severe acute" exact="respiratory" post="syndrome CoV (SARS- CoV) and Middle East respiratory syndrome"/>
 <result pre="(Î²CoV), Gammacoronavirus, and Deltacoronavirus. Two novel Î²CoVs, severe acute respiratory" exact="syndrome" post="CoV (SARS- CoV) and Middle East respiratory syndrome CoV"/>
 <result pre="severe acute respiratory syndrome CoV (SARS- CoV) and Middle East" exact="respiratory" post="syndrome CoV (MERS-CoV), have recently emerged and can induce"/>
 <result pre="acute respiratory syndrome CoV (SARS- CoV) and Middle East respiratory" exact="syndrome" post="CoV (MERS-CoV), have recently emerged and can induce a"/>
 <result pre="2020, infected cases had reached 81â€¯048 in China and a" exact="total" post="of 72â€¯600 cases outside China have been reported to"/>
 <result pre="and territories (https://experience.arcgis.com/experience/685d0ace521648f8a5beeeee1b9125cd). Similar to the SARS-CoV, symptoms of COVID-19" exact="infection" post="at onset of the illness include fever, myalgia, fatigue,"/>
 <result pre="developed dyspnoea. Some patients had radiographic ground-glass lung alterations, and" exact="lower" post="than average circulating lymphocyte and platelet populations. To date,"/>
 <result pre="was estimated as 3.7% for COVID-19 virus (https://experience.arcgis.com/experience/685d0ace521648f8a5beeeee1b9125cd), which is" exact="lower" post="than that of SARS-CoV (10%) or MERS-CoV (37%).1 The"/>
 <result pre="(37%).1 The major challenge of the coronavirus family and similar" exact="infectious" post="agents is that no effective drugs or vaccine are"/>
 <result pre="surfaces (skin-to-skin, touching infected inanimate objects) then mediating the COVID-19" exact="infection" post="through the mouth, nose, or eyes. Transmission can also"/>
 <result pre="Transmission can also be through inhalation of exhaled virus in" exact="respiratory" post="droplets. It has been reported that infectious viruses, including"/>
 <result pre="exhaled virus in respiratory droplets. It has been reported that" exact="infectious" post="viruses, including coronavirus, can survive for long periods outside"/>
 <result pre="transmission via touch. Transmission via the inhalation of small, exhaled" exact="respiratory" post="droplets may occur as the aerosol droplets remain airborne"/>
 <result pre="human-to-human transmission via air movement. The relative contributions of large" exact="respiratory" post="droplets, smaller airborne aerosol, or direct surface contacts to"/>
 <result pre="days.2 In a separate study, coronavirus was reported to remain" exact="infectious" post="in water and sewage for days to weeks.3 At"/>
 <result pre="in airborne particulate matters (PM) or dust is linked to" exact="infectious" post="diseases.5 Poor nation-wide air pollution is frequent in some"/>
 <result pre="of air PM and dust in the transmission of COVID-19" exact="infection" post="remains uninvestigated. Inhalation of virus-laden fine particles could transport"/>
 <result pre="alveolar and tracheobronchial regions, which could increase the chance of" exact="infective" post="transmission. Adsorption of the COVID-19 virus on airborne dust"/>
 <result pre="COVID-19 transmission. The extent to which the COVID-19 virus induces" exact="respiratory" post="stress in infected individuals may also be influenced by"/>
 <result pre="also be influenced by the extent to which an individualâ€™s" exact="respiratory" post="system is already compromised. The high levels of PM"/>
 <result pre="the susceptibility of the population to more serious symptoms and" exact="respiratory" post="complications of the disease. In addition, oxidant pollutants in"/>
 <result pre="with an immune response or cytokine storm induced by COVID-19" exact="infection" post="could enhance the infection severity. Larger numbers of patients"/>
 <result pre="or cytokine storm induced by COVID-19 infection could enhance the" exact="infection" post="severity. Larger numbers of patients displaying more serious infection"/>
 <result pre="the infection severity. Larger numbers of patients displaying more serious" exact="infection" post="symptoms also created an increased risk of enhanced transmission"/>
 <result pre="variety of environmental parameters warrants systematic investigation immediately. Levels of" exact="infectious" post="virus in environmental samples could be low, requiring high-sensitivity"/>
 <result pre="the future, this novel coronavirus may also become a seasonal" exact="infectious" post="virus. The occurrence, survival, and behavior of COVID-19 virus"/>
 <result pre="is clear that the threat of COVID-19 outbreak is not" exact="limited" post="to any single country or region. The response, control,"/>
 <result pre="country or region. The response, control, and prevention of novel" exact="infectious diseases" post="require strong and sustainable international collaborative work and data"/>
 <result pre="scientists in collaborative research is urgently warranted for combating the" exact="infectious disease" post="threat at a global scale. The authors declare no"/>
 <result pre="in collaborative research is urgently warranted for combating the infectious" exact="disease" post="threat at a global scale. The authors declare no"/>
 <result pre="10.1016/S0140-6736(20)30185-9.31986257 WeberD. J.; RutalaW. A.; FischerW. A.; KanamoriH.; Sickbert-BennettE. E.Emerging" exact="infectious" post="diseases: Focus on infection control issues for novel coronaviruses"/>
 <result pre="A.; FischerW. A.; KanamoriH.; Sickbert-BennettE. E.Emerging infectious diseases: Focus on" exact="infection" post="control issues for novel coronaviruses (Severe Acute Respiratory Syndrome-CoV"/>
 <result pre="diseases: Focus on infection control issues for novel coronaviruses (Severe" exact="Acute" post="Respiratory Syndrome-CoV and Middle East Respiratory Syndrome-CoV), hemorrhagic fever"/>
 <result pre="Focus on infection control issues for novel coronaviruses (Severe Acute" exact="Respiratory" post="Syndrome-CoV and Middle East Respiratory Syndrome-CoV), hemorrhagic fever viruses"/>
 <result pre="for novel coronaviruses (Severe Acute Respiratory Syndrome-CoV and Middle East" exact="Respiratory" post="Syndrome-CoV), hemorrhagic fever viruses (Lassa and Ebola), and highly"/>
 <result pre="Syndrome-CoV), hemorrhagic fever viruses (Lassa and Ebola), and highly pathogenic" exact="avian influenza" post="viruses, A(H5N1) and A(H7N9). Am. J. Infect. Control2016, 44"/>
 <result pre="W.; GuanY.; YuenK. Y.; GroupH. U. S. S.Clinical progression and" exact="viral" post="load in a community outbreak of coronavirus-associated SARS pneumonia:"/>
 <result pre="H.; LeungD. Y.; HoT.Evidence of airborne transmission of the severe" exact="acute" post="respiratory syndrome virus. N. Engl. J. Med.2004, 350 (17),"/>
 <result pre="LeungD. Y.; HoT.Evidence of airborne transmission of the severe acute" exact="respiratory" post="syndrome virus. N. Engl. J. Med.2004, 350 (17), 1731â€&quot;9."/>
 <result pre="Y.; HoT.Evidence of airborne transmission of the severe acute respiratory" exact="syndrome" post="virus. N. Engl. J. Med.2004, 350 (17), 1731â€&quot;9. 10.1056/NEJMoa032867.15102999"/>
</results>
